Marc Van Den Bulcke | sciensano.be

Primaire tabs

Zoeken

Limit to

Auteur

Type

Term

Jaar

Trefwoord

Exporteer 71 resultaten:

Filters: Auteur is Marc Van den Bulcke

2024

Contextual factors influencing the equitable implementation of precision medicine in routine cancer care in Belgium, Schmitt, Tugce, Delnord Marie, Cauët Emilie, Van Valckenborgh Els, and Van den Bulcke Marc , European Journal of Public Health, Apr-03-2026, (2024)

Policy brief Belgian EBCP Mirror Group - Artificial Intelligence in cancer care, Cauët, Emilie, Schittecatte Gabrielle, Van den Bulcke Marc, Albarani Valentina, Maati Allaoui, El, Antoine-Poirel H, Baatout Sarah, Broeckx Glenn, Chavez Marcela, Emmanuel Coche, et al. , Archives of Public Health, Jan-08-2024, Volume 82, Issue S1, (2024)

Policy brief Belgian EBCP Mirror Group – cancer research in Belgium, Raicevic, Gordana, Poirel Hélène A., Schittecatte Gabrielle, Van den Bulcke Marc, Andries Camille, Beguin Yves, Bekaert Sofie, Berx Geert, Blanpain Cedric, Breckpot Karine, et al. , Archives of Public Health, Jan-12-2024, Volume 82, Issue S1, (2024)

Unlocking the genomic landscape: Results of the Beyond 1 Million Genomes (B1MG) pilot in Belgium towards Genomic Data Infrastructure (GDI), Schmitt, Tugce, Antoine-Poirel H, Cauët Emilie, Delnord Marie, and Van den Bulcke Marc , Health Policy, Jan-05-2024, Volume 143, (2024)

2022

Precision cancer medicine: What has translated into clinical use in Belgium?, Delnord, Marie, Van Valckenborgh Els, Hébrant Aline, Antoniou Aline, Van Hoof Wannes, Waeytens Anouk, and Van den Bulcke Marc , Seminars in Cancer Biology, 2022, Volume 84, p.255 - 262, (2022)

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment., Thouvenin, J, Van Marcke C, Decoster L, Raicevic Gordana, Punie K, Van den Bulcke Marc, Salgado R, Van Valckenborgh Els, Maes B, Joris S, et al. , ESMO Open, 2022 Aug, Volume 7, Issue 4, (2022)

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors., Konnova, Angelina, De Winter Fien H. R., Akshita Gupta, Hotterbeekx An, Berkell Matilda, and Kumar-Singh Samir , Front Immunol, 2022, Volume 13, (2022)

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx, Konnova, Angelina, De Winter Fien H. R., Akshita Gupta, Verbruggen Lise, Hotterbeekx An, Berkell Matilda, Teuwen Laure-Anne, Vanhoutte Greetje, Peeters Bart, Raats Silke, et al. , Frontiers in Immunology, Oct-12-2023, Volume 13, (2022)

2021

The Belgian practice and attitudes towards introducing genomics in clinical oncology, Van den Bulcke, Marc, Van Hoof Wannes, Van Valckenborgh Els, Hébrant Aline, Raicevic Gordana, and Van Assche Kristof , Belgian journal of medical oncology, 2021, Volume 15, Issue 4, p.177 - 185, (2021)

IPAAC Rapport WP4 : Cancer control policy interview survey, Kiasuwa, Regine, Bakker Laure, and Van den Bulcke Marc , p.48, (2021)

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes., Pannus, Pieter, Neven Kristof Y., De Craeye Stéphane, Heyndrickx Leo, Vande Kerckhove Sara, Georges Daphnée, Michiels Johan, Francotte Antoine, Van den Bulcke Marc, Zrein Maan, et al. , Clin Infect Dis, 2021 Dec 03, (2021)

Precision cancer medicine: What has translated into clinical use in Belgium?, Delnord, Marie, Van Valckenborgh Els, Hébrant Aline, Antoniou Aline, Van Hoof Wannes, Waeytens Anouk, and Van den Bulcke Marc , Semin Cancer Biol, 2021 Jun 12, (2021)

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment., Peeters, M , ESMO Open, 2021 Oct, Volume 6, Issue 5, (2021)

2020

BELGIAN CANCER BAROMETER 2020 Methodology for the working groups, Kiasuwa, Regine, Van Den Broecke M., and Van den Bulcke Marc , (2020)

NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program, Delcourt, Thomas, Vanneste Kevin, Soumali Mohamed Rida, Coucke Wim, Ghislain V, Hébrant Aline, Van Valckenborgh Els, De Keersmaecker Sigrid C. J., Roosens Nancy, Van de Walle P, et al. , Cancers, Jan-11-2020, Volume 12, Issue 11, (2020)

Towards a European health research and innovation cloud (HRIC), Aarestrup, F.M., Albeyatti A., Armitage W. J., Auffray C., Augello L., Balling R., Benhabiles N., Bertolini G., Bjaalie J. G., Black M., et al. , Genome Medicine, Jan-12-2020, Volume 12, Issue 1, (2020)

2019

Algorithms for molecular testing in solid tumours, Hébrant, Aline, Lammens M, Van den Broeck C, D’Haene N., Van den Oord J, Vanderstichele A., Dendooven A, Neven P, Punie K, Floris G, et al. , Belgian Journal of Medical Oncology (BJMO, nov 2019, Volume 13, Issue 7, Number 295, (2019)

Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the commission personalised medicine, Van Valckenborgh, Els, Boone E, Camboni A, Defour JP, Denys B, Devos H, Dewispelaere L, Froyen Guy, Hébrant Aline, Heimann P, et al. , Belgian Journal of Hematology, 2019, Volume 10, Issue 6, Number 249, (2019)

Molecular test algorithms for breast tumours, Hébrant, Aline, Punie K, Duhoux FP, Colpaert C, Floris G, Lambein K, Neven P, Berlière M, Salgado R, Chintinne M, et al. , Belgian Journal of Medical Oncology, 2019, Volume 13, Issue 2, Number 45, (2019)

2018

The genetic structure of the Belgian population, Van den Eynden, Jimmy, Descamps Tine, Delporte Els, Roosens Nancy, De Keersmaecker Sigrid C. J., De Wit Vanessa, Vermeesch Joris Robert, Goetghebeur Els, Tafforeau Jean, Demarest Stefaan, et al. , Human Genomics, Jan-12-2018, Volume 12, Issue 1, (2018)

Opportunities and challenges in oncology and molecular testing: the Belgian strategy, Hébrant, Aline, Van Valckenborgh Els, Salgado Roberto, Froyen Guy, Hulstaert Frank, Roberfroid Dominique, Tejpar Sabine, Jouret-Mourin Anne, Van den Bulcke Marc, and Waeytens Anouk , Belg J Med Oncol , 2018, Volume 12, Issue 2, Number 50, (2018)

Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting., Vermaelen, K, Waeytens A, Kholmanskikh O, Van den Bulcke Marc, and Van Valckenborgh Els , Semin Cancer Biol, 2018 10, Volume 52, Issue Pt 2, (2018)

Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium., Van Valckenborgh, Els, Hébrant Aline, Antoniou Aline, Van Hoof Wannes, Van Bussel Johan, Pauwels Patrick, Salgado Roberto, van Doren Waltruda, Waeytens Anouk, and Van den Bulcke Marc , Arch Public Health, 2018, Volume 76, (2018)

2017

BelPHG-21: a pilot study on genetic variability in the Belgian population, Descamps, Tine, Delporte Els, Vermeesch J, Goetghebeur Els, Clement Lieven, Tafforeau Jean, Demarest Stefaan, Van Oyen Herman, Van den Bulcke Marc, and Van den Eynden Jimmy , European Public Health Conference , Stockholm, (2017)

CanCon European Guide on Quality Improvement in Comprehensive Cancer Control - Chapter 1: Introduction, Albreht, Tit, Van den Bulcke Marc, and Kiasuwa Regine , CanCon, Number 18, (2017)

QR code

QR code for this page URL